scholarly article | Q13442814 |
P50 | author | Eric Verdin | Q37373521 |
Melanie Ott | Q42321952 | ||
Jordan L Meier | Q42408758 | ||
John C Newman | Q97643499 | ||
Tadahiro Shimazu | Q115138374 | ||
P2093 | author name string | Lan Wang | |
Hyung W Lim | |||
Ronen Marmorstein | |||
Sebastian Schröder | |||
Alexander W Sorum | |||
Intelly S Lee | |||
Jasna Maksimoska | |||
Kotaro Shirakawa | |||
Na Man | |||
Stephen Nimer | |||
P2860 | cites work | DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 |
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase | Q24563699 | ||
The ancient drug salicylate directly activates AMP-activated protein kinase | Q24630758 | ||
Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis | Q24646764 | ||
DrugBank: a knowledgebase for drugs, drug actions and drug targets | Q24650300 | ||
CBP/p300-mediated acetylation of histone H3 on lysine 56 | Q24657910 | ||
Structure of the p300 Histone Acetyltransferase Bound to Acetyl-Coenzyme A and Its Analogues | Q27683746 | ||
Chromatin modifications and their function | Q27861067 | ||
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | Q28118359 | ||
Duration of nuclear NF-kappaB action regulated by reversible acetylation | Q28215080 | ||
Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate | Q28278215 | ||
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate | Q28343291 | ||
Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates | Q28609842 | ||
Inhibition of NF-kappa B by sodium salicylate and aspirin | Q29614708 | ||
Andromeda: a peptide search engine integrated into the MaxQuant environment | Q29615816 | ||
Type 2 diabetes as an inflammatory disease | Q29617184 | ||
The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta | Q29617188 | ||
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
Chemoproteomic profiling of lysine acetyltransferases highlights an expanded landscape of catalytic acetylation | Q34489555 | ||
Plant orthologs of p300/CBP: conservation of a core domain in metazoan p300/CBP acetyltransferase-related proteins | Q34578212 | ||
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial | Q35111527 | ||
The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation | Q35650662 | ||
Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. | Q36071867 | ||
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of | Q36657975 | ||
Amino acid conjugation: contribution to the metabolism and toxicity of xenobiotic carboxylic acids | Q36788394 | ||
A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance | Q37101773 | ||
Histone acetyl transferases as emerging drug targets. | Q37540911 | ||
Life and death of transcriptional co-activator p300. | Q37897823 | ||
Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells | Q38288860 | ||
Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat | Q39182760 | ||
AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. | Q39469473 | ||
An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors | Q39722811 | ||
24 Large-scale synthesis of coenzyme A esters | Q41521643 | ||
NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants | Q41831053 | ||
Selective inhibition of cyclooxygenase-1 and -2 using intact insect cell assays | Q42063204 | ||
Regulation of the p300 HAT domain via a novel activation loop. | Q42458138 | ||
CBP/p300 histone acetyl-transferase activity is important for the G1/S transition | Q42801428 | ||
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis | Q42808699 | ||
Regulation of activity of the transcription factor GATA-1 by acetylation | Q42823439 | ||
Small molecule modulators of histone acetyltransferase p300. | Q44353899 | ||
Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector | Q45864375 | ||
In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans. | Q51940716 | ||
Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. | Q52171368 | ||
p300 is required for orderly G1/S transition in human cancer cells. | Q52572534 | ||
Pharmacokinetics of diflunisal in patients | Q70150437 | ||
Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration | Q71059480 | ||
Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs | Q74097807 | ||
Cell-type-specific activation of c-Jun N-terminal kinase by salicylates | Q74614681 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | salicylic acid | Q193572 |
P577 | publication date | 2016-05-31 | |
P1433 | published in | eLife | Q2000008 |
P1476 | title | Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity | |
P478 | volume | 5 |
Q39147132 | A chemical probe toolbox for dissecting the cancer epigenome |
Q90069095 | A genome-wide screen for human salicylic acid (SA)-binding proteins reveals targets through which SA may influence development of various diseases |
Q64254374 | A novel mechanism for the anticancer activity of aspirin and salicylates |
Q51766671 | Aspirin Recapitulates Features of Caloric Restriction. |
Q92547110 | Aspirin Reshapes Acetylomes in Inflammatory and Cancer Cells via CoA-Dependent and CoA-Independent Pathways |
Q64110669 | Aspirin impairs acetyl-coenzyme A metabolism in redox-compromised yeast cells |
Q41072898 | Aspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans |
Q39180002 | Aspirin increases mitochondrial fatty acid oxidation. |
Q38728228 | Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC. |
Q90598267 | Choline supported poly(ionic liquid) graft copolymers as novel delivery systems of anionic pharmaceuticals for anti-inflammatory and anti-coagulant therapy |
Q59132138 | Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells |
Q48117508 | Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes. |
Q41444894 | Diflunisal inhibits prestin by chloride-dependent mechanism |
Q42513461 | Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth |
Q90643583 | Lifespan-increasing drug nordihydroguaiaretic acid inhibits p300 and activates autophagy |
Q48098684 | Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. |
Q58799330 | Recent advances in the understanding and treatment of acute myeloid leukemia |
Q39113288 | Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery. |
Q90999129 | TAF1 plays a critical role in AML1-ETO driven leukemogenesis |
Q92997886 | The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer |
Q38697027 | The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition |
Search more.